<DOC>
	<DOCNO>NCT01985152</DOCNO>
	<brief_summary>The purpose study evaluate Pharmacokinetics safety Azilsartan Trimethylethanolamine healthy volunteer</brief_summary>
	<brief_title>A Phase Ⅰa Study Azilsartan Trimethylethanolamine Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male female Aged 18 year 45 year Body mass index ( BMI ) 19 25kg/m2 Has know sensitivity angiotensin II receptor blocker（ARB） With evidence uncontrolled renal , hepatic , central nervous system , respiratory , cardiovascular , metabolic dysfunction , opinion investigator medical monitor Has know suspect history alcoholism drug abuse misuse With history laboratory result show presence hepatitis B surface antigen ( HBsAg ) , hepatitis C antibody ( HCVAb ) , human immunodeficiency virus ( HIV ) Pregnant , lactating，menstrual Vegetarian Postural hypotension Systolic blood pressure &lt; 100mmHg，or &gt; 130mmHg ; and/or diastolic blood pressure &lt; 70mmHg , &gt; 90mmHg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>